Recombinant human growth hormone in patients with HIV-associated wasting: A randomized, placebo-controlled trial

Annals of Internal Medicine

Volumn 125, Issue 11, 1996, Pages 873-882

  Schambelan, Morris ^m   Mulligan, Kathleen ^m   Grunfeld, Carl ^c   Daar, Eric S ^b   LaMarca, Anthony ^o   Kotler, Donald P ^l   Wang, Jack ^l   Bozzette, Samuel A ^t   Breitmeyer, James B ⁿ   Hurley, A ^a   Javaly, K ^a   Daar, E S ^b   Pitt, J ^b   Grunfeld, C ^c   Pang, M ^c   Heald, A E ^d   Shipp, K W ^d   Pearce, D ^e   Sova, K ^e   Pate, P ^f   Boswell, S L ^g   Flynn, T ^g   Polsky, B ^h   Haverstick, L ⁱ   Rothkopf, M M ⁱ   Bliffen, D L ^j   Rosenfeld, R ^k   Kotler, D P ^l   Pierson Jr , R N ^l   Wang, J ^l   Winson, G ^l   Mulligan, K ^m   Schambelan, M ^m   Tai, V ^m   Bennison, W M ⁿ   Breitmeyer, J B ⁿ   Kennedy, S M ⁿ   Neu, T K ⁿ   Robinson, C E ⁿ   Schwalbert, R J ⁿ   LaMarca, A ^o   LaMarca, D ^o   Bozzette, S A ^p   Kuritzkes, D R ^q   Ray, M G ^q   Mellors, J W ^r   Balser, B E ^s   Balser, J P ^s   more..

^a BELLEVUE HOSPITAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY   (United States)

^e Research Group   (United States)

^f ID Associates   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ Centers for Health Care NJ PA   (United States)

^j METROPLEX CLINICAL RESEARCH CENTER   (United States)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^m SAN FRANCISCO GENERAL HOSPITAL   (United States)

ⁿ EMD SERONO INC   (United States)

^o Therafirst Medical Center   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF COLORADO   (United States)

^r UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^s Veristat Inc   (United States)

^t VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ADULT; AIDS RELATED COMPLEX; ARTHRALGIA; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; EDEMA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; TREATMENT OUTCOME; WASTING SYNDROME; WEIGHT GAIN; WORK CAPACITY;

ADULT; BODY COMPOSITION; BODY WATER; BONE DENSITY; FEMALE; HIV WASTING SYNDROME; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; QUALITY OF LIFE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0030319368     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-11-199612010-00002     Document Type: Article

References (46)

1. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med. 1993;329:1922-6.
2. Weiss PJ, Wallace MR, Olson PE, Rossetti R. Change in the mix of AIDS-defining conditions [Letter]. N Engl J Med. 1993;329:1962.
3. Turner J, Muurahainen N, Terrell C, Graeber C, Kotler C. Nutritional status and quality of life [Abstract]. Int Conf AIDS. 1994;10:35.
4. Palenicek JP, Graham NM, He YD, Hoover DA, Oishi JS, Kingsley L, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;10:366-73.
5. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:239-46.
6. Ott M, Fischer H, Polat H, Helm EB, Frenz M, Caspary WF, et al. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:20-5.
7. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-7.
8. Guenter P, Muurahainen N, Simons G, Kosok A, Cohan GR, Rudenstein R, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr. 1993;6:1130-8.
9. Ehrenpreis ED, Ganger DR, Kochvar GT, Patterson BK, Craig RM. D-xylose malabsorption: characteristic finding in patients with AIDS wasting syndrome and chronic diarrhea. J Acquir Immune Defic Syndr. 1992;5:1047-50.
10. Kotler DP, Tierney AR, Ferraro R, Cuff P, Wang J, Pierson RN Jr, et al. Enteral alimentation and repletion of body cell mass in malnourished patients with acquired immunodeficiency syndrome. Am J Clin Nutr 1991;53:149-54.
11. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN Jr. Effect of home total patenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1990;14: 454-8.
12. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994;121:393-9.
13. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994;121:400-8.
14. Manson JM, Smith RJ, Wilmore DW. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment. Ann Surg. 1988;208:136-42.
15. Ward HC, Halliday D, Sim AJ. Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg. 1987; 206:56-61.
16. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg. 1991;126:38-43.
17. Byrne TA, Morrissey TB, Gatzen C, Benfell K, Nattakom TV, Scheltinga MR, et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg. 1993;218:400-18.
18. Mulligan K, Grunfeld C, Hellerstein MK, Neese RA, Schambelan M. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab. 1993;77:956-62.
19. Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ, et al. Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr. 1993;6:245-51.
20. Society of Actuaries and Association of Life Insurance Medical Directors of America. 1979 Build Study. New York: Metropolitan Life Insurance; 1980:127.
21. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51:1106-12.
22. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo. Am J Clin Nutr. 1993;57:605-8.
23. Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol. 1992;65:895-900.
24. 2H labeled water. Am J Clin Nutr. 1980;33:2686-93.
25. Wong WW, Sheng HP, Morkeberg JC, Kosanovich JL, Clarke LL, Klein PD. Measurement of extracellular water volume by bromide ion chromatography. Am J Clin Nutr. 1989;50:1290-4.
26. Guidelines for Exercise Testing and Prescription. 4th ed. Philadelphia: Lea & Febiger; 1991.
27. Brooks GA, Fahey TD. Exercise Physiology: Human Bioenergetics and Its Applications. New York: Wiley; 1984.
28. Berry SH, Bozzette SA, Hays RD, Stewart AL, Kanouse DE. Measuring Patient-Reported Health Status in Advanced HIV Disease: HIV-PARSE Survey Instrument. Santa Monica, CA: RAND; 1994.
29. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A Perceived Health Index for use in persons with advanced HIV disease: derivation, reliability, and validity. Med Care. 1994;32:716-31.
30. Bozzette SA, Kanouse DE, Berry S, Duan N, Roche Study Group. Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group. JAMA. 1995;273:295-301.
31. Rosenfeld RG, Wilson DM, Lee PD, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr. 1986;109:428-33
32. Povolotsky J, Polsky B, Abrams E, Gold J, Liu KN, Dedyo T, et al. Acid treatment of sera from HIV-1 infected children substantially increases the sensitivity of the HIV-1 p24 antigen immunoassay. Pediatric AIDS and HIV Infection: Fetus to Adolescent. 1992;3:108-11.
33. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, et al. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:446-54.
34. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med. 1995;122:573-9.
35. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol. 1991;70:688-94.
36. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J. Ingemann-Hansen T, Skakkebaek NE, et al. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989;1:1221-5.
37. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol. 1991;70:695-700.
38. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321:1797-803.
39. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindsledt G, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993;76:309-17.
40. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, et al. Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother. 1993;27:827-31.
41. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10:89-97.
42. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MR, Boyden CM, The Body Cell Mass and Its Surrounding Environment: Body Composition in Health and Disease. Philadelphia: WB Saunders; 1963.
43. Laurence J, Grimison B, Gonenne A. Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro. Blood. 1992;79:467-72.
44. Ritzen EM. Does growth hormone increase the risk of malignancies? Horm Res. 1993;39:99-101.
45. Tuffli GA, Johanson A, Rundle AC, Allen DB. Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone. J Clin Endocrinol Metab. 1995;80:1416-22.
46. Fradkin JE, Mills JL, Schonberger LB, Wysowski DK, Thomson R, Durako SJ, et al. Risk of leukemia after treatment with pituitary growth hormone. JAMA. 1993;270:2829-32.